Ronald Asbury Andrews - Net Worth and Insider Trading

Ronald Asbury Andrews Net Worth

The estimated net worth of Ronald Asbury Andrews is at least $133,904 dollars as of 2023-02-06. Ronald Asbury Andrews is the President & CEO of OncoCyte Corp and owns about 333,212 shares of OncoCyte Corp (OCX) stock worth over $133,318. Ronald Asbury Andrews is also the President, Medical Sciences of aTyr Pharma Inc and owns about 238 shares of aTyr Pharma Inc (LIFE) stock worth over $585. Details can be seen in Ronald Asbury Andrews's Latest Holdings Summary section.

Transaction Summary of Ronald Asbury Andrews

To

Ronald Asbury Andrews Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ronald Asbury Andrews owns 3 companies in total, including OncoCyte Corp (OCX) , Oxford Immunotec Global PLC (OXFD) , and Precipio Inc (PRPO) .

Click here to see the complete history of Ronald Asbury Andrews’s form 4 insider trades.

Insider Ownership Summary of Ronald Asbury Andrews

Ticker Comapny Transaction Date Type of Owner
OCX OncoCyte Corp 2018-08-30 director
OXFD Oxford Immunotec Global PLC 2020-06-24 director
PRPO Precipio Inc 2021-03-01 director

Ronald Asbury Andrews Latest Holdings Summary

Ronald Asbury Andrews currently owns a total of 2 stocks. Among these stocks, Ronald Asbury Andrews owns 333,212 shares of OncoCyte Corp (OCX) as of August 16, 2022, with a value of $133,318 and a weighting of 99.56%. Ronald Asbury Andrews also owns 238 shares of aTyr Pharma Inc (LIFE) as of April 27, 2012, with a value of $585 and a weighting of 0.44%.

Latest Holdings of Ronald Asbury Andrews

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCX OncoCyte Corp 2022-08-16 333,212 0.40 133,318
LIFE aTyr Pharma Inc 2012-04-27 238 2.46 585

Holding Weightings of Ronald Asbury Andrews


Ronald Asbury Andrews Form 4 Trading Tracker

According to the SEC Form 4 filings, Ronald Asbury Andrews has made a total of 6 transactions in OncoCyte Corp (OCX) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 40,000 shares on August 16, 2022, which cost Ronald Asbury Andrews around $38,400.

According to the SEC Form 4 filings, Ronald Asbury Andrews has made a total of 0 transactions in aTyr Pharma Inc (LIFE) over the past 5 years. The most-recent trade in aTyr Pharma Inc is the acquisition of 238 shares on April 27, 2012, which cost Ronald Asbury Andrews around $154,812.

Insider Trading History of Ronald Asbury Andrews

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
OCX
OncoCyte Corp
2022-08-16
Buy
40,000.00
13.64%
$0.96
$38,400.00
333,212.00
$0.40
-58.32%
2022-08-18
OCX
OncoCyte Corp
2022-03-16
Buy
50,000.00
20.56%
$1.28
$64,000.00
293,212.00
$0.40
-68.74%
2022-03-17
OCX
OncoCyte Corp
2021-03-19
Buy
11,000.00
10.71%
$4.79
$52,690.00
113,698.00
$0.40
-91.65%
-
OCX
OncoCyte Corp
2020-08-03
Buy
40,000.00
63.80%
$1.35
$54,000.00
102,698.00
$0.40
-70.36%
-
OCX
OncoCyte Corp
2020-03-31
Buy
45,216.00
258.64%
$2.30
$103,997.00
62,698.00
$0.40
-82.60%
-
OCX
OncoCyte Corp
2020-03-31
Buy
45,216.00
258.64%
$945.63
$42,757,600.00
62,698.00
$0.40
-99.96%
-
LIFE
aTyr Pharma Inc
2012-04-27
Buy
237.86
7.69%
$650.86
$154,812.00
237.86
$2.46
-99.62%
-
Total 7
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ronald Asbury Andrews Trading Performance

GuruFocus tracks the stock performance after each of Ronald Asbury Andrews's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ronald Asbury Andrews is -21.03%. GuruFocus also compares Ronald Asbury Andrews's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ronald Asbury Andrews within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ronald Asbury Andrews's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ronald Asbury Andrews

Average Relative Return

89.56%

Average relative return per transaction

Outperforming Transactions

75%

3 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -3.56 -21.03 21.19 89.56 -23.46
Relative Return to S&P 500(%) -7.07 -25.35 5.18 50.63 -49.16

Ronald Asbury Andrews Ownership Network

Ownership Network List of Ronald Asbury Andrews

No Data

Ownership Network Relation of Ronald Asbury Andrews


Ronald Asbury Andrews Owned Company Details


Ronald Asbury Andrews Mailing Address

Above is the net worth, insider trading, and ownership report for Ronald Asbury Andrews. You might contact Ronald Asbury Andrews via mailing address: 5791 Van Allen Way, Carlsbad Ca 92008.